CureGene
Suzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A gene and cell therapy company developing potentially curative treatments for cancer and genetic diseases.
OncologyGenetic Disorders
Technology Platform
An integrated platform for developing gene and cell therapies, encompassing gene editing, viral vector delivery, and immune cell engineering.
Opportunities
Potential to develop curative, single-administration therapies for cancers or genetic diseases with significant market need.
Risk Factors
Faces substantial scientific, manufacturing, safety, and regulatory hurdles inherent to gene and cell therapy development.
Competitive Landscape
Competes in the high-growth but crowded and technically demanding global gene and cell therapy sector.